West Pharmaceutical Services Inc (WST)
316.59
-4.29
(-1.34%)
USD |
NYSE |
Nov 22, 16:00
316.53
-0.06
(-0.02%)
After-Hours: 20:00
West Pharmaceutical Services Cash from Investing (Quarterly): -82.10M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -82.10M |
| June 30, 2024 | -101.20M |
| March 31, 2024 | -90.60M |
| December 31, 2023 | -108.80M |
| September 30, 2023 | -95.70M |
| June 30, 2023 | -82.10M |
| March 31, 2023 | -82.10M |
| December 31, 2022 | -94.80M |
| September 30, 2022 | -59.10M |
| June 30, 2022 | -66.00M |
| March 31, 2022 | -68.30M |
| December 31, 2021 | -77.40M |
| September 30, 2021 | -65.30M |
| June 30, 2021 | -55.90M |
| March 31, 2021 | -54.50M |
| December 31, 2020 | -57.60M |
| September 30, 2020 | -49.10M |
| June 30, 2020 | -40.90M |
| March 31, 2020 | -31.90M |
| December 31, 2019 | -120.60M |
| September 30, 2019 | -31.60M |
| June 30, 2019 | -47.10M |
| March 31, 2019 | -28.70M |
| December 31, 2018 | -28.60M |
| September 30, 2018 | -26.50M |
| Date | Value |
|---|---|
| June 30, 2018 | -17.00M |
| March 31, 2018 | -28.70M |
| December 31, 2017 | -29.40M |
| September 30, 2017 | -34.00M |
| June 30, 2017 | -35.50M |
| March 31, 2017 | -34.70M |
| December 31, 2016 | -46.70M |
| September 30, 2016 | -47.90M |
| June 30, 2016 | -42.60M |
| March 31, 2016 | -38.60M |
| December 31, 2015 | -43.90M |
| September 30, 2015 | -29.50M |
| June 30, 2015 | -25.50M |
| March 31, 2015 | -30.60M |
| December 31, 2014 | -26.30M |
| September 30, 2014 | -20.70M |
| June 30, 2014 | -21.40M |
| March 31, 2014 | -35.60M |
| December 31, 2013 | -38.90M |
| September 30, 2013 | -29.10M |
| June 30, 2013 | -24.20M |
| March 31, 2013 | -57.70M |
| December 31, 2012 | -22.70M |
| September 30, 2012 | -25.50M |
| June 30, 2012 | -35.90M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-120.60M
Minimum
Dec 2019
-31.90M
Maximum
Mar 2020
-74.20M
Average
-72.85M
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp | -5.859M |
| Perspective Therapeutics Inc | -29.74M |
| Retractable Technologies Inc | 2.926M |
| Xtant Medical Holdings Inc | -2.009M |
| Catheter Precision Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 180.10M |
| Cash from Financing (Quarterly) | -64.40M |
| Free Cash Flow | 321.60M |
| Free Cash Flow Per Share (Quarterly) | 1.346 |
| Free Cash Flow to Equity (Quarterly) | 102.00M |
| Free Cash Flow to Firm (Quarterly) | 98.80M |
| Free Cash Flow Yield | 1.37% |